In this article, we examine how multiomics is advancing disease research, particularly in neurodegenerative disorders such as ...
Key opportunities include rising demand for biologics characterization, driven by advancements in drug development and monoclonal antibody therapiesDublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The "Mass ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results